Dundas Partners LLP Zoetis Inc. Transaction History

Dundas Partners LLP

$1.27 Billion
Q1 2024

A detailed history of Dundas Partners LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Dundas Partners LLP holds 129,406 shares of ZTS stock, worth $22.4 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

129,406

Previous 129,406 -0.0%

Holding current value

$22.4 Million

Previous $25.5 Million 14.27%

% of portfolio

1.72%

Previous 2.23%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$167.14 - $192.77 $2.52 Million - $2.9 Million	15,067 Added 13.18%	129,406 $22.5 Million
Q1 2023 May 12, 2023	BUY	$145.48 - $175.02 $2.71 Million - $3.25 Million	18,596 Added 19.42%	114,339 $19 Million
Q4 2022 Feb 08, 2023	BUY	$131.14 - $157.47 $805,593 - $967,338	6,143 Added 6.86%	95,743 $14 Million
Q2 2022 Aug 12, 2022	BUY	$155.97 - $200.09 $951,105 - $1.22 Million	6,098 Added 7.3%	89,600 $15.4 Million
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $3.86 Million - $4.98 Million	21,273 Added 34.19%	83,502 $15.7 Million

Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $3.69 Million - $4.71 Million	-19,067 Reduced 23.45%	62,229 $12.4 Million
Q4 2019 Feb 07, 2020	BUY	$116.25 - $133.25 $104,625 - $119,925	900 Added 1.12%	81,296 $10.8 Million
Q3 2019 Nov 01, 2019	SELL	$112.57 - $128.43 $4.19 Million - $4.78 Million	-37,233 Reduced 31.65%	80,396 $10 Million
Q3 2018 Nov 13, 2018	SELL	$83.5 - $93.23 $1.62 Million - $1.81 Million	-19,362 Reduced 14.13%	117,629 $13.4 Million
Q2 2018 Jul 26, 2018	SELL	$79.9 - $89.2 $2.09 Million - $2.33 Million	-26,156 Reduced 16.03%	136,991 $11.7 Million
Q1 2018 Jun 06, 2018	BUY	$71.51 - $84.69 $11.7 Million - $13.8 Million	163,147 New	163,147 $13 Million

Others Institutions Holding ZTS

# of Institutions

1,857

Shares Held

416M

Call Options Held

1.13M

Put Options Held

1.81M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dundas Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Dundas Partners LLP with notifications on news.

Account

Dundas Partners LLP Zoetis Inc. Transaction History